Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.
Abionic has raised $83K in total funding. The most recent round was Grant. The last funding was announced in June 2023.
Abionic's investors include Verve Ventures, Zürcher Kantonal Bank, Venture Kick, Polytech Ventures, Business Angels Switzerland (BAS).
Abionic is headquartered in Lausanne, Switzerland.
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.
Abionic is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Abionic — Funding & Investors." VCBacked, June 13, 2023, https://www.vcbacked.co/company/abionic. Accessed August 13, 2026.
VCBacked. (2023). Abionic — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/abionic
{{cite web |title=Abionic — Funding & Investors |url=https://www.vcbacked.co/company/abionic |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated